The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Murray Richard /ca/ since 2006.
This trader's CIK number is 1242935.
At the time of last reporting, Murray Richard /ca/ was the Officer of Jounce Therapeutics, Inc.. (stock ticker symbol JNCE).
Also see all insider trading activities at Jounce Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | PDLI | 0 | $0 | 0 | $0 | 20,000 | $157,000 |
| 2006 | PDLI | 0 | $0 | 15,000 | $480,046 | 15,000 | $154,740 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | JNCE | 0 | $0 | 84,298 | $122,645 | 0 | $0 |
| 2022 | JNCE | 0 | $0 | 37,294 | $256,695 | 0 | $0 |
| 2021 | JNCE | 0 | $0 | 141,999 | $1,394,018 | 120,000 | $57,599 |
| 2020 | JNCE | 0 | $0 | 7,150 | $55,627 | 0 | $0 |
| 2019 | JNCE | 0 | $0 | 40,000 | $334,799 | 40,000 | $19,200 |
| 2018 | JNCE | 0 | $0 | 32,668 | $763,369 | 64,668 | $31,040 |
2. Jounce Therapeutics, Inc. (JNCE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-04-28 | PDLI | Option Ex | 20,000 | 7.85 | 157,000 |
| 2006-03-03 | PDLI | Sale | 2,327 | 32.02 | 74,510 |
| 2006-03-06 | PDLI | Sale | 12,673 | 32.00 | 405,536 |
| 2006-03-03 | PDLI | Option Ex | 15,000 | 10.32 | 154,740 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-04-04 | JNCE | Sale | 39,228 | 1.85 | 72,571 |
| 2023-01-09 | JNCE | Sale | 20,191 | 1.10 | 22,210 |
| 2023-01-10 | JNCE | Sale | 24,879 | 1.12 | 27,864 |
| 2022-01-10 | JNCE | Sale | 23,924 | 6.65 | 159,094 |
| 2022-01-07 | JNCE | Sale | 13,370 | 7.30 | 97,601 |
| 2021-01-21 | JNCE | Sale | 33,518 | 12.06 | 404,227 |
| 2021-01-21 | JNCE | Option Ex | 33,518 | .48 | 16,088 |
| 2021-01-19 | JNCE | Sale | 40,000 | 9.59 | 383,600 |
| 2021-01-20 | JNCE | Sale | 16,482 | 12.04 | 198,443 |
| 2021-01-15 | JNCE | Option Ex | 30,000 | .48 | 14,400 |
| 2021-01-15 | JNCE | Sale | 30,000 | 8.54 | 256,199 |
| 2021-01-19 | JNCE | Option Ex | 40,000 | .48 | 19,200 |
| 2021-01-20 | JNCE | Option Ex | 16,482 | .48 | 7,911 |
| 2021-01-07 | JNCE | Sale | 10,183 | 6.76 | 68,837 |
| 2021-01-08 | JNCE | Sale | 11,816 | 7.00 | 82,712 |
| 2020-01-07 | JNCE | Sale | 7,150 | 7.78 | 55,627 |
| 2019-12-23 | JNCE | Sale | 40,000 | 8.37 | 334,799 |
| 2019-12-23 | JNCE | Option Ex | 40,000 | .48 | 19,200 |
| 2018-09-06 | JNCE | Option Ex | 32,000 | .48 | 15,360 |
| 2018-03-08 | JNCE | Sale | 16,334 | 25.10 | 409,983 |
| 2018-03-08 | JNCE | Option Ex | 16,334 | .48 | 7,840 |
| 2018-03-05 | JNCE | Option Ex | 16,334 | .48 | 7,840 |
| 2018-03-05 | JNCE | Sale | 16,334 | 21.64 | 353,386 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Murray Richard /ca/ (Officer of Jounce Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.